LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Relative Growth Rate After Treatment
MDA-MB-231 CGP60474
0.12
uM
LJP6
 2
G05
 72
hr
 868 861 3486 0.2470 -0.0027
MDA-MB-231 CGP60474
0.12
uM
LJP6
 3
G05
 72
hr
 868 854 3486 0.2450 -0.0054
MDA-MB-231 CHIR-99021
0.12
uM
LJP6
 1
P17
 72
hr
 868 2874 3486 0.8244 0.7661
MDA-MB-231 CHIR-99021
0.12
uM
LJP6
 2
P17
 72
hr
 868 2791 3486 0.8005 0.7344
MDA-MB-231 CHIR-99021
0.12
uM
LJP6
 3
P17
 72
hr
 868 2733 3486 0.7839 0.7123
MDA-MB-231 CP724714
0.12
uM
LJP5
 1
A11
 72
hr
 868 2720 3486 0.7802 0.7073
MDA-MB-231 CP724714
0.12
uM
LJP5
 2
A11
 72
hr
 868 2339 3486 0.6709 0.5618
MDA-MB-231 CP724714
0.12
uM
LJP5
 3
A11
 72
hr
 868 2818 3486 0.8083 0.7447
MDA-MB-231 CP466722
0.12
uM
LJP5
 1
I11
 72
hr
 868 3702 3486 1.0618 1.0823
MDA-MB-231 CP466722
0.12
uM
LJP5
 2
I11
 72
hr
 868 3819 3486 1.0954 1.1270
MDA-MB-231 CP466722
0.12
uM
LJP5
 3
I11
 72
hr
 868 3534 3486 1.0137 1.0182
MDA-MB-231 Crizotinib
0.12
uM
LJP5
 1
A23
 72
hr
 868 2709 3486 0.7770 0.7031
MDA-MB-231 Crizotinib
0.12
uM
LJP5
 2
A23
 72
hr
 868 2839 3486 0.8143 0.7527
MDA-MB-231 Crizotinib
0.12
uM
LJP5
 3
A23
 72
hr
 868 2789 3486 0.8000 0.7336
MDA-MB-231 Momelotinib
0.12
uM
LJP5
 1
P11
 72
hr
 868 2304 3486 0.6609 0.5484
MDA-MB-231 Momelotinib
0.12
uM
LJP5
 2
P11
 72
hr
 868 3079 3486 0.8832 0.8444
MDA-MB-231 Momelotinib
0.12
uM
LJP5
 3
P11
 72
hr
 868 2641 3486 0.7575 0.6771
MDA-MB-231 Dasatinib
0.12
uM
LJP5
 1
D05
 72
hr
 868 686 3486 0.1968 -0.0696
MDA-MB-231 Dasatinib
0.12
uM
LJP5
 2
D05
 72
hr
 868 811 3486 0.2326 -0.0218
MDA-MB-231 Dasatinib
0.12
uM
LJP5
 3
D05
 72
hr
 868 713 3486 0.2045 -0.0592
MDA-MB-231 Dasatinib
0.12
uM
LJP6
 1
I05
 72
hr
 868 632 3486 0.1813 -0.0902
MDA-MB-231 Dasatinib
0.12
uM
LJP6
 2
I05
 72
hr
 868 639 3486 0.1833 -0.0875
MDA-MB-231 Dasatinib
0.12
uM
LJP6
 3
I05
 72
hr
 868 474 3486 0.1360 -0.1505
MDA-MB-231 Dovitinib
0.12
uM
LJP5
 1
E23
 72
hr
 868 2392 3486 0.6861 0.5820
MDA-MB-231 Dovitinib
0.12
uM
LJP5
 2
E23
 72
hr
 868 2415 3486 0.6927 0.5908